The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Open accessAbstract
Antibiotics (ABX) compromise the efficacy of programmed cell death protein 1 (PD-1) blockade in cancer patients, but the mechanisms underlying their immunosuppressive effects remain unknown. By inducing the down-regulation of mucosal addressin cell adhesion molecule 1 (MAdCAM-1) in the ileum, post-ABX gut recolonization by Enterocloster species drove the emigration of enterotropic α4β7 + CD4 + regulatory T 17 cells into the tumor. These deleterious ABX effects were mimicked by oral gavage of Enterocloster species, by genetic deficiency, or by antibody-mediated neutralization of MAdCAM-1 and its receptor, α4β7 integrin. By contrast, fecal microbiota transplantation or interleukin-17A neutralization prevented ABX-induced immunosuppression. In independent lung, kidney, and bladder cancer patient cohorts, low serum levels of soluble MAdCAM-1 had a negative prognostic impact. Thus, the MAdCAM-1–α4β7 axis constitutes an actionable gut immune checkpoint in cancer immunosurveillance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intestinal dysbiosis, broadly defined as an imbalance in the composition or function of the gut microbiota, is a significant contributor to resistance against immune checkpoint inhibitor (ICI) therapies.1–16,”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“Antibiotics predictably inflict the most acute damage, reducing diversity, depleting beneficial commensals, and permitting blooms of pathobionts like Enterocloster and Streptococcus.4,27,98”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“For instance, our lab has shown that antibiotic-induced dysbiosis spurs the downregulation of mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1; discussed below) via altered BA metabolism (Fig. 3h).4”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“Our lab recently reported that low baseline sMAdCAM-1 levels are strongly associated with gut dysbiosis in cancer patients.4,24”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“This, in turn, allows immunosuppressive gut-resident α4β7+FoxP3+ regulatory Th17 (Tr17) cells to exit the gut and migrate to peripheral tumors, where they can blunt local antitumor immunity.4”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
26 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Self-citationQuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447 · cited 1×
“I mmune checkpoint inhibitors (ICIs) targeting the immunosuppressive interaction between programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) are used in the clinical management of many cancer types (1, 2).”
MethodGut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · cited 3×
“Moreover, FMT from some human donors fails to improve ICI responses (7, 35).”
BackgroundMethodSelf-citationIpilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830 · cited 1×
“, A novel endothelial L-selectin ligand activity in lymph node medulla that is regulated by alpha(1,3)fucosyltransferase-IV.”
BackgroundMultivariable association discovery in population-scale meta-omics studies
Mallick, H., Rahnavard, A., McIver, L. J., Ma, S., Zhang, Y., Nguyen, L. H., Tickle, T. L., Weingart, G., Ren, B., Schwager, E. H., et al. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009442 · Cited by 2,596
Cited by
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Hu, Y., Hu, Q., Li, Y., Lu, L., Xiang, Z., Yin, Z., Kabelitz, D., & Wu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01653-8 · Cited by 382
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Thomas, A. M., Fidelle, M., Routy, B., Kroemer, G., Wargo, J. A., Segata, N., & Zitvogel, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00785-8 · Cited by 141
Self-citationRole of the microbiota in response to and recovery from cancer therapy
Blake, S. J., Wolf, Y., Boursi, B., & Lynn, D. J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00951-0 · Cited by 158
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
Zhang, M., Liu, J., & Xia, Q. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00442-x · Cited by 167
Immunosurveillance in clinical cancer management
Kroemer, G., Chan, T. A.-T., Eggermont, A. M. M., & Galluzzi, L. (2023) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21818 · Cited by 177
Self-citation
Metadata
- Authors
- Fidelle, M., Rauber, C., Alves Costa Silva, C., Tian, A.-L., Lahmar, I., de La Varende, A.-L. M., Zhao, L., Thelemaque, C., Lebhar, I., Messaoudene, M., Pizzato, E., Birebent, R., Mbogning Fonkou, M. D., Zoppi, S., Reni, A., Dalban, C., Leduc, M., Ferrere, G., Durand, S., Ly, P., Silvin, A., Mulder, K., Dutertre, C.-A., Ginhoux, F., Yonekura, S., Roberti, M. P., Tidjani-Alou, M., Terrisse, S., Chen, J., Kepp, O., Schippers, A., Wagner, N., Suárez-Gosálvez, J., Kobold, S., Fahrner, J.-E., Richard, C., Bosq, J., Lordello, L., Vitali, G., Galleron, N., Quinquis, B., Le Chatelier, E., Blanchard, L., Girard, J.-P., Jarry, A., Gervois, N., Godefroy, E., Labarrière, N., Koschny, R., Daillère, R., Besse, B., Truntzer, C., Ghiringhelli, F., Coatnoan, N., Mhanna, V., Klatzmann, D., Drubay, D., Albiges, L., Thomas, A. M., Segata, N., Danlos, F.-X., Marabelle, A., Routy, B., Derosa, L., Kroemer, G., & Zitvogel, L.
- Affiliations
- Inserm (FR)
- Gustave Roussy Cancer Campus, Villejuif Cedex, France.
- Centre Hospitalier de l’Université de Montréal (CA)
- University of Parma (IT)
- University of Verona (IT)
- Centre Léon Bérard (FR)
- Universitätsklinikum Aachen (DE)
- Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Munich, Germany.
- Center for Integrated Protein Science Munich (DE)
- JBO Consultant, Paris, France.
- Université Paris-Saclay (FR)
- MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
- Centre National de la Recherche Scientifique (FR)
- University Hospital Heidelberg (DE)
- Institut Gustave Roussy (FR)
- University of Trento (IT)
- Corresponding author
- Fidelle, Marine
- Rauber, Conrad
- Derosa, Lisa
- Kroemer, Guido
- Zitvogel, Laurence
- ORCID
- Fidelle, Marine
- Rauber, Conrad
- Alves Costa Silva, Carolina
- Tian, Ai-Ling
- Zhao, Liwei
- Messaoudene, Meriem
- Birebent, Roxanne
- Mbogning Fonkou, Maxime Descartes
- Zoppi, Silvia
- Reni, Anna
- Dalban, Cécile
- Leduc, Marion
- Ferrere, Gladys
- Durand, Sylvère
- Ly, Pierre
- Silvin, Aymeric
- Mulder, Kevin
- Dutertre, Charles-Antoine
- Ginhoux, Florent
- Yonekura, Satoru
- Roberti, Maria Paula
- Tidjani-Alou, Maryam
- Terrisse, Safae
- Chen, Jianzhou
- Kepp, Oliver
- Schippers, Angela
- Wagner, Norbert
- Suárez-Gosálvez, Javier
- Kobold, Sebastian
- Fahrner, Jean-Eudes
- Richard, Corentin
- Bosq, Jacques
- Lordello, Leonardo
- Galleron, Nathalie
- Quinquis, Benoît
- Le Chatelier, Emmanuelle
- Blanchard, Lucas
- Girard, Jean-Philippe
- Jarry, Anne
- Gervois, Nadine
- Godefroy, Emmanuelle
- Labarrière, Nathalie
- Koschny, Ronald
- Daillère, Romain
- Besse, Benjamin
- Truntzer, Caroline
- Ghiringhelli, François
- Coatnoan, Nicolas
- Mhanna, Vanessa
- Klatzmann, David
- Drubay, Damien
- Albiges, Laurence
- Thomas, Andrew Maltez
- Segata, Nicola
- Danlos, François-Xavier
- Marabelle, Aurélien
- Routy, Bertrand
- Derosa, Lisa
- Kroemer, Guido
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2023-06-09
- Volume
- 380
- Issue
- 6649
- Pages
- eabo2296-eabo2296
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4379780265
- Cited by
- 243
- References
- 83
- Citations by year
- 2026: 74 · 2025: 86 · 2024: 58 · 2023: 25
- FWCI
- 29.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (publishedVersion)
- HAL (submittedVersion)
- HAL (submittedVersion, other-oa)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, cc-by)
- Funders
- Agence Nationale de la Recherche (ANR-16-RHUS-0001, ANR-21-ESRE-0028, ANR-18-IBHU-0002, ANR-19-CE15-0029, ANR-21-RHUS-0017, ANR-18-IDEX-0001)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- antibiotics, gut microbiota, MAdCAM-1, alpha4beta7 integrin, regulatory T cells, anti-PD-1 therapy, tumor immunosuppression, Enterocloster, fecal microbiota transplantation, IL-17A, prognostic factors, lung cancer, kidney cancer, bladder cancer
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors, Animals, Anti-Bacterial Agents, Bacteria, Cell Movement, Humans, Immune Tolerance, Immunologic Surveillance, Mucoproteins, Neoplasms, Cell Adhesion Molecules, Integrins, Drug Resistance, Neoplasm, Interleukin-17, Gastrointestinal Tract, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers. https://app.cochat.ai/papers/10.1126/science.abo2296
- The paper
- Fidelle, M., Rauber, C., Alves Costa Silva, C., Tian, A.-L., Lahmar, I., de La Varende, A.-L. M., Zhao, L., Thelemaque, C., Lebhar, I., Messaoudene, M., Pizzato, E., Birebent, R., Mbogning Fonkou, M. D., Zoppi, S., Reni, A., Dalban, C., Leduc, M., Ferrere, G., Durand, S., . . . Zitvogel, L. (2023). A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers. Science. https://doi.org/10.1126/science.abo2296
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.